Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022126180 - CCR6 ANTIBODIES

Publication Number WO/2022/126180
Publication Date 23.06.2022
International Application No. PCT/AU2021/051488
International Filing Date 14.12.2021
IPC
A61K 39/395 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A61P 37/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
A61P 17/06 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
06Antipsoriatics
Applicants
  • MONASH UNIVERSITY [AU]/[AU]
Inventors
  • ROBERT, Remy
  • MACKAY, Charles Reay
Agents
  • FPA PATENT ATTORNEYS PTY LTD
Priority Data
202090465314.12.2020AU
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) CCR6 ANTIBODIES
(FR) ANTICORPS ANTI-CCR6
Abstract
(EN) The invention relates to CCR6, to antibodies and related fragments thereof for binding to said receptors, to production of said antibodies and fragments and to use of said antibodies and fragments for detection and therapy of various conditions, in particular autoimmune diseases, inflammation, infection, oncology and fibrosis.
(FR) L'invention concerne le CCR6, des anticorps et des fragments associés de ceux-ci pour la liaison auxdits récepteurs, la production desdits anticorps et fragments et l'utilisation desdits anticorps et fragments pour la détection et la thérapie de divers états, en particulier les maladies auto-immunes, l'inflammation, l'infection, les tumeurs et la fibrose.
Latest bibliographic data on file with the International Bureau